Universal Insurance Holdings, Inc. (NYSE: UVE) will issue a press release reporting its third quarter results after the close of trading on the NYSE on Tuesday, October 27, 2020. The company will host a conference call on Wednesday, October 28, 2020, at 9:00 a.m. Eastern Time (ET) to discuss its third quarter 2020 financial results.


Conference Call and Webcast


  • Wednesday, October 28, 2020 at 9:00 a.m. ET

  • U.S Dial-in Number: (855) 752-6647

  • International: (503) 343-6667

  • Participant code: 5317328

  • Listen to live webcast and view presentation: UniversalInsuranceHoldings.com

  • Replay of the call will be available on the UVE website and by phone at (855) 859-2056 or internationally at (404) 537-3406 using the participant code: 5317328 through November 12, 2020


About Universal Insurance Holdings, Inc.


Universal Insurance Holdings (UVE) is a holding company offering property and casualty insurance and value-added insurance services. We develop, market, and write insurance products for consumers predominantly in the personal residential homeowners lines of business and perform substantially all other insurance-related services for our primary insurance entities, including risk management, claims management and distribution. We sell insurance products through both our appointed independent agents and through our direct online distribution channels in the United States across 18 states (primarily Florida). Learn more at UniversalInsuranceHoldings.com.

Source Article

M.D.C. Holdings (MDC) is a buy for the total return and dividend income investor. M.D.C. Holdings is among the largest homebuilders in the United States and has an increasing owned backlog of over 17,000 lots to develop and options on another 7,000.

The company has steady growth and has the cash it uses to develop new properties and homes for the average home buyer. The lower interest rates give a tailwind to the company business. The Fed has indicated that they intend to keep interest rates low for at least a year or maybe two.

As I have said before in previous articles.

I use a set of guidelines that I codified over the last few years to review the companies in The Good Business Portfolio (my portfolio) and other companies that I am reviewing. For a complete set of guidelines, please see my article “The Good Business Portfolio: Update to Guidelines, March 2020”. These guidelines provide me with a balanced portfolio of income, defensive, total return, and growing companies that hopefully keeps me ahead of the Dow average.

When I scanned the five-year chart, M.D.C Holdings has a good chart going up and to the right for 2016, 2017, and 2019 in a strong solid pattern. It is a cyclic company and was down in 2015 and has recovered well in 2019 from the flat year of 2018. 2020 was doing good until the pandemic hit, then it went down like a rock in water but has recovered nicely in the past six months. The PE is low at 11, and the earnings growth looks good at 10%, making MDC a strong buy.

ChartData by YCharts

Fundamentals and company business review

The method I use to compare companies is to look at the total return, as shown from my

Johnson & Johnson  (JNJ) – Get Report continues to trade well, bubbling just below its prior all-time high. 

That has investors wondering if the healthcare juggernaut can notch new records after reporting earnings on Tuesday before the stock market opens. In fact, the charts are looking pretty familiar.

Shares of J&J traded down into the 200-day moving average ahead of earnings in July. Then the stock began to climb higher in anticipation of the results. While the upside reaction wasn’t overwhelmingly bullish, it was still positive.

It’s what allowed shares of Johnson & Johnson to continue higher, ultimately making new highs in early September.

Will the stock repeat its actions?

Johnson & Johnson is a holding in Jim Cramer’s Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells JNJ? Learn more now.

Trading Johnson & Johnson

Daily chart of Johnson & Johnson stock.

Daily chart of Johnson & Johnson stock.

Johnson & Johnson is working on its fourth straight daily rally, while Monday’s strength should be no surprise given the broader market’s surge.

The stock put in a higher low in October vs. its September low, while reclaiming the 20-day and 50-day moving averages with its recent rally. That low in September came on a test of the 200-day moving average, which has been support so far this summer.

When measuring the September range, J&J shares were able to hit the 78.6% retracement on Monday, near $152.70.

Now bulls want to see a bullish rotation, not just over the 78.6% retracement, but over key resistance near $155. A move over this zone is vital for a breakout to occur.

If Johnson & Johnson can clear this mark and close above it, it opens the door to the $161 to $163 area. Near $161 it

JPMorgan Chase  (JPM) – Get Report is often considered a best-in-breed bank stock, which is why investors will be looking for the company to be a leader as this earnings season kicks off.

JPMorgan will report earnings on Tuesday before the open along with Citigroup  (C) – Get Report and ahead of others like Bank of America  (BAC) – Get Report, Wells Fargo  (WFC) – Get Report and Goldman Sachs  (GS) – Get Report.

Unlike the S&P 500, which has made new 52-week highs, JPMorgan and the banks continue to struggle.

While off the lows, plenty of technical damage remains. Investors will look to see if management is less cautious than it was in the summer and if the consumer is looking better or worse from three months ago.

If investors like what they hear, it could trigger a nice move higher for JPMorgan and its peers this quarter. If not, it could put bulls in a tough spot as we progress through the fourth quarter.

JPMorgan and Goldman Sachs are holdings in Jim Cramer’s Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells JPM or GS? Learn more now.

Trading JPMorgan Stock

Daily chart of JPMorgan stock.

Daily chart of JPMorgan stock.

Surprisingly, when the rest of the market was pulling back in the first half of September, JPMorgan stock held steady. The decline in tech was spilling over into the indices, but not into the financials. However, the group couldn’t hold up forever.

JPMorgan stock ended up selling off in the second half of September and testing down into range support near $90.

Since testing into support, JPMorgan stock has rebounded sharply, reclaiming the 20-day and 50-day moving averages in

The third-quarter reporting cycle is finally here. PACCAR Inc. PCAR is set to kick off the earnings season for the Auto-Tires-Trucks sector next week.

Per the Oct 9 Earnings Preview, the auto sector’s earnings tanked 123.5% on a 49.7% revenue slump during the second quarter. However, things seem to be gradually looking up for the sector. While earnings and revenues are expected to have declined in the September-end quarter as well, these declines are likely to be less severe. In the third quarter, overall earnings and revenues for the sector are projected to fall 35.1% and 4.8%, year over year.

Dismal Q2 Performance

The coronavirus outbreak hit the auto industry hard in the latter half of the first quarter and the second quarter. The pandemic hurt the industry significantly amid factory closures, low footfall at dealerships and supply-chain distortions. Depressed demand of vehicles amid waning consumer confidence has dented the margins of most automakers across the globe. Amid the coronavirus crisis-induced lockdown, with thousands of people working from homes, consumers had put off big-ticket purchases like cars, causing the global auto sales to plummet during the April-June period.

Per the S&P Global Market Intelligence analysis, U.S. auto sales plunged 33.3% year over year in the second quarter, with the overall non-seasonally adjusted U.S. vehicle sales for the period summing up to 2.95 million units, down from the 2019 figure of 4.42 million units. Notably, vehicle sales from each of the Detroit 3 carmakers — Ford, General Motors and Fiat Chrysler — dropped year over year during the June-end quarter.

U.S. Auto Industry Gathered Momentum in Q3

The pandemic has significantly transformed the auto industry. With social distancing becoming the new normal, people are avoiding public transportation, which makes private transportation the need of the hour. Remarkably, U.S. auto sales are